Literature DB >> 9372557

Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET.

J Logan1, N D Volkow, J S Fowler, G J Wang, M W Fischman, R W Foltin, N N Abumrad, S Vitkun, S J Gatley, N Pappas, R Hitzemann, C E Shea.   

Abstract

The concentration (Bmax) of the dopamine transporter (DAT) and the maximum and effective occupancies by cocaine doses of 0.1 mg/kg or 0.05 mg/kg were measured in the striatum of cocaine abusers (n = 12) by using [11C]cocaine as a radiotracer for the DAT and positron emission tomography (PET). Two methods based on a three-compartment model with one binding site (the nonlinear least squares (NLSQ) and the Farde pseudoequilibrium method) were used to estimate Bmax. Effective occupancies and maximum occupancies were calculated from the distribution volume ratios (DVR) and a three-compartment model, respectively. The NLSQ and Farde methods gave similar values of Bmax (average, 650 +/- 350 pmol/ml and 776 +/- 400 pmol/ml, respectively), but the individual estimates of Bmax were found to be very sensitive to small variations in other model parameters and were not correlated with the parameter Bmax/Kd (r = .07). The average maximum (and effective) occupancies were found to be 67% (50%) and 52% (39%) for the 0.1-mg/kg and the 0.05-mg/kg studies, respectively. The ED50 based on the effective occupancy corresponds to 0.1 mg/kg, which is significantly smaller than the ED50 of 3 mg/kg calculated from studies in which [123]beta-CIT is displaced by cocaine. The effect on the Bmax estimate of two binding sites with different Kd's is also considered by simulation. We conclude (1) that the lack of robustness in the Bmax estimate limits the usefulness of any one subject's Bmax and suggests that the combination parameter Bmax/Kd (or the DVR), which has been used extensively, is a more stable measure of free receptor/transporter concentration. The average Bmax may, however, provide an estimate of the expected concentration in humans. (2) The DVR can be used as a measure of DAT occupancy without applying an explicit model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372557     DOI: 10.1002/(SICI)1098-2396(199712)27:4<347::AID-SYN8>3.0.CO;2-C

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  9 in total

Review 1.  Current concepts in pharmacotherapy of substance abuse.

Authors:  P C Gottschalk; L K Jacobsen; T R Kosten
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Elizabeth O Ahlers; Maxim Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-04       Impact factor: 6.200

Review 3.  DARK Classics in Chemical Neuroscience: Cocaine.

Authors:  Lindsey R Drake; Peter J H Scott
Journal:  ACS Chem Neurosci       Date:  2018-04-24       Impact factor: 4.418

4.  Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging.

Authors:  Wynne K Schiffer; David L Alexoff; Colleen Shea; Jean Logan; Stephen L Dewey
Journal:  J Neurosci Methods       Date:  2004-12-08       Impact factor: 2.390

5.  Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo.

Authors:  Tomas Drgon; Zhicheng Lin; Gene-Jack Wang; Joanna Fowler; Johnfn Pablo; Deborah C Mash; Nora Volkow; George R Uhl
Journal:  Cell Mol Neurobiol       Date:  2006-05-20       Impact factor: 5.046

6.  Measurement of density and affinity for dopamine D(2) receptors by a single positron emission tomography scan with multiple injections of [(11)C]raclopride.

Authors:  Yoko Ikoma; Hiroshi Watabe; Takuya Hayashi; Yoshinori Miyake; Noboru Teramoto; Kotaro Minato; Hidehiro Iida
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

7.  The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.

Authors:  Bradley T Christian; Nicholas T Vandehey; Andrew S Fox; Dhanabalan Murali; Terrence R Oakes; Alex K Converse; Robert J Nickles; Steve E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Neuroimage       Date:  2008-10-29       Impact factor: 6.556

8.  Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence.

Authors:  N Fernàndez-Castillo; J Cabana-Domínguez; J Soriano; C Sànchez-Mora; C Roncero; L Grau-López; E Ros-Cucurull; C Daigre; M M J van Donkelaar; B Franke; M Casas; M Ribasés; B Cormand
Journal:  Transl Psychiatry       Date:  2015-10-27       Impact factor: 6.222

9.  Mapping human brain capillary water lifetime: high-resolution metabolic neuroimaging.

Authors:  William D Rooney; Xin Li; Manoj K Sammi; Dennis N Bourdette; Edward A Neuwelt; Charles S Springer
Journal:  NMR Biomed       Date:  2015-04-27       Impact factor: 4.044

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.